Literature DB >> 21338149

Mass spectrometry reveals that the antibiotic simocyclinone D8 binds to DNA gyrase in a "bent-over" conformation: evidence of positive cooperativity in binding.

Marcus J Edwards1, Mark A Williams, Anthony Maxwell, Adam R McKay.   

Abstract

DNA topoisomerases are enzymes that control DNA topology and are vital targets for antimicrobial and anticancer drugs. Here we present a mass spectrometry study of complexes formed between the A subunit of the topoisomerase DNA gyrase and the bifunctional inhibitor simocyclinone D8 (SD8), an antibiotic isolated from Streptomyces. These studies show that, in an alternative mode of interaction to that found by X-ray crystallography, each subunit binds a single bifunctional inhibitor with separate binding pockets for the two ends of SD8. The gyrase subunits form constitutive dimers, and fractional occupancies of inhibitor-bound states show that there is strong allosteric cooperativity in the binding of two bifunctional ligands to the dimer. We show that the mass spectrometry data can be fitted to a general model of cooperative binding via an extension of the "tight-binding" approach, providing a rigorous determination of the dissociation constants and degree of cooperativity. This general approach will be applicable to other systems with multiple binding sites and highlights mass spectrometry's role as a powerful emerging tool for unraveling the complexities of biomolecular interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338149     DOI: 10.1021/bi101691k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.

Authors:  Shantanu Karkare; Terence T H Chung; Frederic Collin; Lesley A Mitchenall; Adam R McKay; Sandra J Greive; Jacobus J M Meyer; Namrita Lall; Anthony Maxwell
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

Review 2.  Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.

Authors:  Frédéric Collin; Shantanu Karkare; Anthony Maxwell
Journal:  Appl Microbiol Biotechnol       Date:  2011-09-09       Impact factor: 4.813

3.  SimC7 Is a Novel NAD(P)H-Dependent Ketoreductase Essential for the Antibiotic Activity of the DNA Gyrase Inhibitor Simocyclinone.

Authors:  Martin Schäfer; Tung B K Le; Stephen J Hearnshaw; Anthony Maxwell; Gregory L Challis; Barrie Wilkinson; Mark J Buttner
Journal:  J Mol Biol       Date:  2015-04-08       Impact factor: 5.469

Review 4.  Structural insights into simocyclinone as an antibiotic, effector ligand and substrate.

Authors:  Mark J Buttner; Martin Schäfer; David M Lawson; Anthony Maxwell
Journal:  FEMS Microbiol Rev       Date:  2018-01-01       Impact factor: 16.408

5.  Application of a novel microtitre plate-based assay for the discovery of new inhibitors of DNA gyrase and DNA topoisomerase VI.

Authors:  James A Taylor; Lesley A Mitchenall; Martin Rejzek; Robert A Field; Anthony Maxwell
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

6.  A new crystal structure of the bifunctional antibiotic simocyclinone D8 bound to DNA gyrase gives fresh insight into the mechanism of inhibition.

Authors:  Stephen J Hearnshaw; Marcus J Edwards; Clare E Stevenson; David M Lawson; Anthony Maxwell
Journal:  J Mol Biol       Date:  2014-03-01       Impact factor: 5.469

7.  Substrate-Assisted Catalysis in Polyketide Reduction Proceeds via a Phenolate Intermediate.

Authors:  Martin Schäfer; Clare E M Stevenson; Barrie Wilkinson; David M Lawson; Mark J Buttner
Journal:  Cell Chem Biol       Date:  2016-09-08       Impact factor: 8.116

8.  Versatility of 7-Substituted Coumarin Molecules as Antimycobacterial Agents, Neuronal Enzyme Inhibitors and Neuroprotective Agents.

Authors:  Erika Kapp; Hanri Visser; Samantha L Sampson; Sarel F Malan; Elizabeth M Streicher; Germaine B Foka; Digby F Warner; Sylvester I Omoruyi; Adaze B Enogieru; Okobi E Ekpo; Frank T Zindo; Jacques Joubert
Journal:  Molecules       Date:  2017-09-30       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.